Drug Type Gene therapy |
Synonyms Interleukin-2 gene medicine ((Valentis, Inc.)), Interleukin-2 gene therapy (Valentis), VLTS-587 |
Target |
Action inhibitors |
Mechanism IL-2 inhibitors(Interleukin-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 2 | Czechia | - | - |
Head and Neck Neoplasms | Phase 2 | Germany | - | - |
Head and Neck Neoplasms | Phase 2 | Russia | - | - |
Head and Neck Neoplasms | Phase 2 | - | - | |
Melanoma | Phase 2 | United States | - | - |
Melanoma | Phase 2 | - | - | |
Lung Cancer | Phase 1 | United States | - | - |
Lung Cancer | Phase 1 | - | - |